Point-counterpoint: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; Two promising combinations - No definite conclusions

2002-02-05

Additional Metadata
Keywords	Cervical cancer, Cisplatin, Hyperthermia, Radiotherapy, Therapeutic ratio
Persistent URL	doi.org/10.1080/02656730110083738, hdl.handle.net/1765/66199
Journal	International Journal of Hyperthermia
Organisation	Department of Gynaecology & Obstetrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van der Zee, J., Koper, P., Lutgens, L., & Burger, C. (2002). Point-counterpoint: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; Two promising combinations - No definite conclusions. International Journal of Hyperthermia (Vol. 18, pp. 19–24). doi:10.1080/02656730110083738

Publication